Chimera Investment Corporation
NYSE:CIMREIT - Mortgage
+$0.12 today
- Market cap
- $541.62M
- Beta
- 1.76
- P/E (TTM)
- 58.1
- EPS (TTM)
- $0.23
- Dividend yield
- 11.65%
Volume 1.98M
Average 0.70M
CIM Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Chimera Investment CorporationNYSE: CIM
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $9.65M rose 914.6% year over year, behind the +1624.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 122.7% from the prior quarter. Over 3 fiscal years it compounded at -51.1% a year.
Context
- Depreciation & amortization amounted to 0.9% of revenue in FY2025, up 0.8 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +914.6% toward the trailing-twelve-month pace of +1624.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 7.18M USD
- Year-over-year change
- +2137.7%
- 4-year CAGR
- -43.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.18M | +2137.7% |
| FY2024 | 2024-12-31 | 321K | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 61.49M | -12.9% |
| FY2021 | 2021-12-31 | 70.58M | — |
Depreciation & Amortization vs competitors
How CIM compares with its peers on the latest reported figures
- CIM's LTM Mar 2026 depreciation & amortization of $16.4M is the 3rd highest of the 9 companies compared; the peer median is $3.44M.
- Its year-over-year change of +1624.7% is the highest of 6, against a peer median of -46.9%.
- Depreciation & amortization amounts to 2.6% of revenue for CIM, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $27.75M | -16.6% | +18.4% | 0.4% | |
| LTM Mar 2026 | $26.57M | -66.9% | -30.3% | 2.2% | |
| LTM Mar 2026 | $16.4M | +1624.7% | -51.1% | 2.6% | |
| LTM Jun 2026 | $5.79M | — | -50.3% | 0.7% | |
| LTM Mar 2026 | $5.18M | — | — | 0.7% | |
| LTM Mar 2026 | $1.7M | -46.9% | -37.9% | 0.2% | |
| LTM Mar 2026 | $669K | +5.4% | — | 0.2% | |
| LTM Sep 2026 | $0 | -100.0% | +138.8% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CIM) | $3.44M | -46.9% | -30.3% | 0.3% | |
Competitors are the stored peer set for CIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.06B | (415.21M) | 204.77M | 257.93M | 820.77M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 42.1M |
| Gross Profit | 1.06B | (415.21M) | 204.77M | 257.93M | 778.67M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 94.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 69.07M | 72.03M | 55.69M | 64.57M | 30M |
| Operating Expenses | 1.06B | (415.21M) | 204.77M | 257.93M | 14.01M |
| Depreciation & Amortization | 70.58M | 61.49M | 0 | 321K | 7.18M |
| EBITDA | 1.07B | (118.54M) | 635.75M | 672.71M | 794.87M |
| EBITDA Margin | 101.4% | 28.5% | 310.5% | 260.8% | 96.8% |
| Operating Income | 0 | 0 | 0 | 0 | 764.65M |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 93.2% |
| Interest Income | 937.55M | 773.12M | 772.9M | 760.95M | 821.86M |
| Interest Expense | 326.63M | 333.29M | 509.54M | 496.27M | 554.92M |
| Other Income / Expenses | 674.52M | (513.32M) | 126.21M | 176.11M | (531.89M) |
| Income Before Tax | 674.52M | (513.32M) | 126.21M | 176.11M | 232.77M |
| Pre-Tax Margin | 63.8% | 123.6% | 61.6% | 68.3% | 28.4% |
| Income Tax Expense | 4.41M | (253K) | 102K | 49K | 2.27M |
| Net Income | 670.11M | (513.07M) | 126.1M | 176.07M | 230.5M |
| Net Margin | 63.4% | 123.6% | 61.6% | 68.3% | 28.1% |
| EPS (Basic) | 7.65 | (2.19) | 0.55 | 1.12 | 2.80 |
| EPS (Diluted) | 2.43 | (2.19) | 0.54 | 1.10 | 2.75 |
| Weighted Avg Shares | 77.92M | 77.98M | 76.64M | 80.99M | 82.18M |
| Weighted Avg Shares (Diluted) | 81.83M | 77.98M | 78.14M | 82.16M | 83.94M |
Chimera Investment Corporation
NYSE:CIM
Intrinsic Alpha fair value
Locked
Current Price
$6.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.